Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/13/2014US8722690 Mesoionic pesticides
05/13/2014US8722688 Compounds for the treatment of hepatitis C
05/13/2014US8722687 Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy
05/13/2014US8722686 Hydroxamic acid derivatives useful as antibacterial agents
05/13/2014US8722685 Pyrazine derivatives and uses thereof in renal monitoring
05/13/2014US8722684 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
05/13/2014US8722683 Benzodioxole piperazine compounds
05/13/2014US8722682 Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity
05/13/2014US8722681 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases
05/13/2014US8722680 Method of treating neurodegenerative diseases
05/13/2014US8722679 Controlled release sterile injectable aripiprazole formulation and method
05/13/2014US8722677 Viral inhibitors
05/13/2014US8722676 Bicyclic piperazine compounds
05/13/2014US8722675 Method of treatment or prophylaxis
05/13/2014US8722674 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same
05/13/2014US8722673 Imine compounds for combating invertebrate pests
05/13/2014US8722672 Topical pharmaceutical composition including rel-N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4′-(trifluoromethoxY)-[1,1′-biphenyl]-3-carboxamide
05/13/2014US8722671 Isoquinoline derivatives
05/13/2014US8722670 Selective NR2B antagonists
05/13/2014US8722669 Compounds and methods of treating ocular disorders
05/13/2014US8722668 Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
05/13/2014US8722667 Compositions and methods for inhibiting the proliferation of cells
05/13/2014US8722666 Sedative for use during eye surgery
05/13/2014US8722665 Cinnamido-pyrrolo[2,1-C][1,4]benzodiazepines as potential anticancer agents and process for the preparation thereof
05/13/2014US8722664 Spontaneously dispersible N-benzoyl staurosporine compositions
05/13/2014US8722663 Di-substituted pyridine derivatives as anticancers
05/13/2014US8722662 Heterocyclic compounds
05/13/2014US8722661 Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
05/13/2014US8722660 Heterocyclic compound
05/13/2014US8722659 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
05/13/2014US8722658 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/13/2014US8722657 Salts and crystalline forms of an apoptosis-inducing agent
05/13/2014US8722656 Cephalosporins useful as antibacterial agents
05/13/2014US8722655 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia
05/13/2014US8722654 Lipoxin analogs as novel inhibitors of angiogenesis
05/13/2014US8722653 Method for treating uterine fibroids
05/13/2014US8722652 Acute treatment of social phobia
05/13/2014US8722651 Methods and products for treatment of diseases
05/13/2014US8722650 Extended-release minocycline dosage forms
05/13/2014US8722649 Alpha-chloro and alpha-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof
05/13/2014US8722648 Liquid pharmaceutical form of alkylphosphocholine and method for preparing same
05/13/2014US8722647 Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
05/13/2014US8722646 High concentration chitosan-nucleic acid polyplex compositions
05/13/2014US8722645 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
05/13/2014US8722644 Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
05/13/2014US8722636 Animal treatments
05/13/2014US8722634 Use of compounds extracted from Momordica charantia L. in the manufacture of medicaments for prevention and treatment of diabetes and obesity
05/13/2014US8722616 Anti-HIV peptides and methods of use thereof
05/13/2014US8722613 Methods and compositions for inhibition of nuclear factor kappaB
05/13/2014US8722580 Agent for inhibiting cytokinin signaling
05/13/2014US8722384 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
05/13/2014US8722332 Macrocyclic lactone resistance marker for dirofilaria immitis
05/13/2014US8722113 Compositions comprising extracts of southernwood and an amine compound
05/13/2014US8722111 Modified pectins, compositions and methods related thereto
05/13/2014US8722107 Modified pectins, compositions and methods related thereto
05/13/2014US8722106 Lip balm composition
05/13/2014US8722104 Composition containing organic substance having double bond with improved oxidative stability
05/13/2014US8722102 Compositions for treatment of skin and ear infections
05/13/2014US8722093 Policosanol nanoparticles
05/13/2014US8722092 Nanoparticles made of amorphous cellulose
05/13/2014US8722091 Preparation of submicron sized nanoparticles via dispersion lyophilization
05/13/2014US8722087 Titration dosing regimen for controlled release tramadol
05/13/2014US8722085 Methods for administering weight loss medications
05/13/2014US8722084 Controlled release preparation
05/13/2014US8722083 Fenofibrate formulation
05/13/2014US8722081 Hemostatic textile material
05/13/2014US8722066 Devices and methods for weight control and weight loss
05/13/2014US8722064 Synthetic glucopyranosyl lipid adjuvants
05/13/2014US8722051 Tweak receptor
05/13/2014US8722037 X-ray visible drug delivery device
05/13/2014US8722032 Thiol-selective water-soluble polymer derivatives
05/13/2014US8721963 Cold sterilization of tissue engineering scaffolds with compressed carbon dioxide
05/13/2014US8720436 Nitric oxide gel apparatus and method
05/13/2014CA2795006C Purine compounds used as cb2 agonists
05/13/2014CA2758144C Cyclic compound having substituted phenyl group
05/13/2014CA2756750C A method for producing bicyclic .gamma.-amino acid derivative
05/13/2014CA2748895C Pharmaceutical compositions with superior product performance and patient compliance
05/13/2014CA2725001C Dihydroindolone derivatives
05/13/2014CA2697978C Lower dosage strength imiquimod formulations and short dosing regimens for treating genital warts
05/13/2014CA2677631C Olopatadine formulations for topical nasal administration
05/13/2014CA2676401C Stable pharmaceutical compositions and methods of making and using same
05/13/2014CA2665226C Novel formulations of proton pump inhibitors and methods of using these formulations
05/13/2014CA2661702C Method for producing phenoxypyridine derivative
05/13/2014CA2659967C Quinazoline derivatives
05/13/2014CA2654270C Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
05/13/2014CA2648653C Fat accumulation inhibitor
05/13/2014CA2648086C Methods and compositions for inducing an immune response to hiv and models for testing
05/13/2014CA2645093C Use of adenine-derived compounds for the treatment of lupus
05/13/2014CA2643668C Salt of cd 80 antagonist
05/13/2014CA2642602C Substituted arylsulfonamides as antiviral agents
05/13/2014CA2637316C A pharmaceutical composition comprising perindopril
05/13/2014CA2634542C Incontinence treatment methods
05/13/2014CA2633686C Compositions and methods for preventing or treating inflammatory bowel disease
05/13/2014CA2631654C [(1h-indol-5-yl)-heteroaryloxy]-(1-aza-bicyclo[3.3.1]nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders
05/13/2014CA2623721C Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
05/13/2014CA2623031C Antifungal composition
05/13/2014CA2618524C Pyrazole derivatives having tyrosine kinase activity
05/13/2014CA2611712C Combretastatin analogs with tubulin binding activity
05/13/2014CA2601628C Certain substituted amides, method of making, and method of use thereof
05/13/2014CA2600761C Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors
1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 7860